ArticleThe Lancet regional health. Europe2026
Community-acquired bacterial meningitis in adults in Denmark (2015-2023): a prospective, nationwide, population-based cohort study.
Article in The Lancet regional health. Europe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bridging the diagnostic gap: the role of culture methods in the era of syndromic panels for central nervous system infections.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Data on clinical presentation and care pathways of community-acquired bacterial meningitis (CABM) remain scarce, especially in relation to whether and how pathogens are detected. This study aimed to examine clinical phenotypes of CABM. Methods: Nationwide, prospective, population-based cohort study of all adults diagnosed with CABM in Denmark from 2015 to 2023. Patients were hierarchically categorised as: 1) Positive cerebrospinal fluid (CSF) cultures, 2) Positive CSF polymerase chain reaction (PCR) tests or microscopy, 3) Positive blood cultures and CSF pleocytosis, 4) Other microbiological tests and CSF pleocytosis, and 5) Unknown pathogen and CSF pleocytosis. Findings: Among 1192 CABM episodes in 1174 adults (median age 65 years [interquartile range 52-75]; 597/1192 [50%] females), main pathogens were Interpretation: Distinct clinical phenotypes were associated with differences in pathogen distributions, timely diagnosis, treatment, and outcome. This knowledge is crucial for improvements in healthcare pathways and analyses of guideline adherence. Funding: Jacob Bodilsen was supported by the Danish Independent Research Foundation (10.46540/5243-00013B).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.